Upstream Bio, Inc. (UPB) has a market capitalization of $537.13M and trades at $9.87. The 52-week range is 5.14-33.68.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.7, Earnings Per Share (EPS) of $-2.66, annual revenue of $2.85M.
The stock has a beta of 2.99, operates in the Healthcare sector.
